United States Biotechnology & Medical Research

Applied Genetic Technologies Corp (AGTC)

Track

Ticker: AGTC Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Applied Genetic Technologies Corp. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Potter Stephen W Chief Business Officer Officer
Transaction date
Sale
Price
259.96
Quantity 12,937 -23.5%
Value US$3,931,521
Reynolds Gerald Anthony Chief Accounting Officer Officer
Transaction date
Sale
Price
289.13
Quantity 56,282 +21.9%
Value US$1,671,451
3.3
Washer Susan B. President and CEO Executive Director
Transaction date
Sale
Price
340.93
Quantity 40,214 +43.4%
Value US$4,488,023
Krol Patrick Johan Hendrik Large shareholder
Transaction date
Sale
Price
5.24
Quantity 81,162 -4.4%
Value US$425,289
Krol Patrick Johan Hendrik Large shareholder
Transaction date
Purchase
Price
2.79
Quantity 2,544 +0.1%
Value US$7,098
Shearman Mark S Chief Scientific Officer Officer
Transaction date
Sale
Price
3.35
Quantity 3,000 -100.0%
Value US$10,053
Washer Susan B. President and CEO Executive Director
Transaction date
Purchase
Price
3.34
Quantity 2,380 +11.7%
Value US$7,949
Rosen James Non-Executive Director
Transaction date
Purchase
Price
3.38
Quantity 1,000 +inf%
Value US$3,381
Sullivan William A. Chief Financial Officer Officer
Transaction date
Purchase
Price
3.33
Quantity 3,000 +inf%
Value US$9,990
Aliski William Non-Executive Director
Transaction date
Purchase
Price
3.24
Quantity 500 +6.2%
Value US$1,620
Aliski William Non-Executive Director
Transaction date
Purchase
Price
3.25
Quantity 4,300 +116.2%
Value US$13,975
Aliski William Non-Executive Director
Transaction date
Purchase
Price
3.24
Quantity 1,200 +48.0%
Value US$3,882
Magovcevic Ivana Non-Executive Director
Transaction date
Purchase
Price
9.63
Quantity 3,000 +inf%
Value US$28,875
Chulay Jeffrey D. VP and Chief Medical Officer Officer
Transaction date
Planned sale
Price
7.05
Quantity 1,000 -4.7%
Value US$7,052
Shearman Mark S Chief Scientific Officer Officer
Transaction date
Purchase
Price
8.87
Quantity 1,300 +76.5%
Value US$11,531
Shearman Mark S Chief Scientific Officer Officer
Transaction date
Purchase
Price
8.87
Quantity 1,700 +inf%
Value US$15,070
Potter Stephen W See Remarks Officer
Transaction date
Purchase
Price
8.69
Quantity 400 +40.0%
Value US$3,476
BULLOCK LAWRENCE E Chief Financial Officer Officer
Transaction date
Purchase
Price
8.75
Quantity 10,000 +inf%
Value US$87,500
Potter Stephen W See Remarks Officer
Transaction date
Purchase
Price
8.97
Quantity 1,000 +inf%
Value US$8,970
GLAXOSMITHKLINE PLC
Transaction date
Sale
Price
22.00
Quantity 503,150 -25.9%
Value US$11,069,602
Menichella Daniel L V.P. & Chief Business Officer Officer
Transaction date
Sale
Price
24.90
Quantity 1,996 -100.0%
Value US$49,700
Menichella Daniel L V.P. & Chief Business Officer Officer
Transaction date
Sale
Price
20.83
Quantity 9,000 -100.0%
Value US$187,470
GLAXOSMITHKLINE PLC Large shareholder
Transaction date
Sale
Price
21.01
Quantity 12,000 -0.6%
Value US$252,136
GLAXOSMITHKLINE PLC Large shareholder
Transaction date
Sale
Price
21.00
Quantity 8,000 -0.4%
Value US$168,000
GLAXOSMITHKLINE PLC Large shareholder
Transaction date
Sale
Price
21.24
Quantity 7,500 -0.4%
Value US$159,294
GLAXOSMITHKLINE PLC Large shareholder
Transaction date
Sale
Price
21.28
Quantity 12,500 -0.6%
Value US$266,035
GLAXOSMITHKLINE PLC Large shareholder
Transaction date
Sale
Price
21.18
Quantity 10,000 -0.5%
Value US$211,760
GLAXOSMITHKLINE PLC Large shareholder
Transaction date
Purchase
Price
12.00
Quantity 103,762 +5.5%
Value US$1,245,144
Rosen James Non-Executive Director Large shareholder
Transaction date
Purchase
Price
12.00
Quantity 62,871 +5.5%
Value US$754,452
MedImmune Ventures, Inc. Large shareholder
Transaction date
Purchase
Price
12.00
Quantity 75,735 +5.5%
Value US$908,820
INTERWEST PARTNERS VIII LP Large shareholder
Transaction date
Purchase
Price
12.00
Quantity 75,376 +5.5%
Value US$904,512
Alta Partners VIII, L.P. Large shareholder
Transaction date
Purchase
Price
12.00
Quantity 155,645 +5.5%
Value US$1,867,740
Wu Samuel Non-Executive Director Large shareholder
Transaction date
Purchase
Price
12.00
Quantity 75,735 +5.5%
Value US$908,820
Carroll Jill Non-Executive Director Large shareholder
Transaction date
Purchase
Price
12.00
Quantity 103,762 +5.5%
Value US$1,245,144
ORONSKY ARNOLD L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
12.00
Quantity 75,736 +5.5%
Value US$908,832
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-07-01 2022-07-01 S Sale
Potter Stephen W

Chief Business Officer

Officer
12,937 -23.5%
259.96
US$3,931,521 		12,937 -23.5% 259.96 US$3,931,521
2022-05-31 2022-05-27 S Sale
Reynolds Gerald Anthony

Chief Accounting Officer

Officer
56,282 +21.9%
289.13
US$1,671,451 		56,282 +21.9% 289.13 US$1,671,451
2022-02-22 2022-02-18 S Sale
3.3
Washer Susan B.

President and CEO

Executive Director
40,214 +43.4%
340.93
US$4,488,023 		40,214 +43.4% 340.93 US$4,488,023
2019-12-30 2019-12-26 S Sale Krol Patrick Johan Hendrik Large shareholder
81,162 -4.4%
5.24
US$425,289 		81,162 -4.4% 5.24 US$425,289
2019-11-26 2019-11-19 B Purchase Krol Patrick Johan Hendrik Large shareholder
2,544 +0.1%
2.79
US$7,098 		2,544 +0.1% 2.79 US$7,098
2018-12-18 2018-12-14 S Sale Shearman Mark S

Chief Scientific Officer

Officer
3,000 -100.0%
3.35
US$10,053 		3,000 -100.0% 3.35 US$10,053
2018-12-18 2018-12-14 B Purchase Washer Susan B.

President and CEO

Executive Director
2,380 +11.7%
3.34
US$7,949 		2,380 +11.7% 3.34 US$7,949
2018-12-18 2018-12-14 B Purchase Rosen James Non-Executive Director
1,000 +inf%
3.38
US$3,381 		1,000 +inf% 3.38 US$3,381
2018-12-18 2018-12-14 B Purchase Sullivan William A.

Chief Financial Officer

Officer
3,000 +inf%
3.33
US$9,990 		3,000 +inf% 3.33 US$9,990
2018-12-18 2018-12-14 B Purchase Aliski William Non-Executive Director
500 +6.2%
3.24
US$1,620 		500 +6.2% 3.24 US$1,620
2018-12-18 2018-12-14 B Purchase Aliski William Non-Executive Director
4,300 +116.2%
3.25
US$13,975 		4,300 +116.2% 3.25 US$13,975
2018-12-18 2018-12-14 B Purchase Aliski William Non-Executive Director
1,200 +48.0%
3.24
US$3,882 		1,200 +48.0% 3.24 US$3,882
2016-11-17 2016-11-16 B Purchase Magovcevic Ivana Non-Executive Director
3,000 +inf%
9.63
US$28,875 		3,000 +inf% 9.63 US$28,875
2016-11-02 2016-11-01 PlS Planned sale Chulay Jeffrey D.

VP and Chief Medical Officer

Officer
1,000 -4.7%
7.05
US$7,052 		1,000 -4.7% 7.05 US$7,052
2016-09-26 2016-09-22 B Purchase Shearman Mark S

Chief Scientific Officer

Officer
1,300 +76.5%
8.87
US$11,531 		1,300 +76.5% 8.87 US$11,531
2016-09-26 2016-09-22 B Purchase Shearman Mark S

Chief Scientific Officer

Officer
1,700 +inf%
8.87
US$15,070 		1,700 +inf% 8.87 US$15,070
2016-09-27 2016-09-20 B Purchase Potter Stephen W

See Remarks

Officer
400 +40.0%
8.69
US$3,476 		400 +40.0% 8.69 US$3,476
2016-09-20 2016-09-19 B Purchase BULLOCK LAWRENCE E

Chief Financial Officer

Officer
10,000 +inf%
8.75
US$87,500 		10,000 +inf% 8.75 US$87,500
2016-09-27 2016-09-16 B Purchase Potter Stephen W

See Remarks

Officer
1,000 +inf%
8.97
US$8,970 		1,000 +inf% 8.97 US$8,970
2015-02-24 2015-02-23 S Sale GLAXOSMITHKLINE PLC
503,150 -25.9%
22.00
US$11,069,602 		503,150 -25.9% 22.00 US$11,069,602
2015-01-26 2015-01-23 S Sale Menichella Daniel L

V.P. & Chief Business Officer

Officer
1,996 -100.0%
24.90
US$49,700 		1,996 -100.0% 24.90 US$49,700
2014-12-23 2014-12-22 S Sale Menichella Daniel L

V.P. & Chief Business Officer

Officer
9,000 -100.0%
20.83
US$187,470 		9,000 -100.0% 20.83 US$187,470
2015-02-12 2014-12-18 S Sale GLAXOSMITHKLINE PLC Large shareholder
12,000 -0.6%
21.01
US$252,136 		12,000 -0.6% 21.01 US$252,136
2015-02-12 2014-12-17 S Sale GLAXOSMITHKLINE PLC Large shareholder
8,000 -0.4%
21.00
US$168,000 		8,000 -0.4% 21.00 US$168,000
2015-02-12 2014-12-12 S Sale GLAXOSMITHKLINE PLC Large shareholder
7,500 -0.4%
21.24
US$159,294 		7,500 -0.4% 21.24 US$159,294
2015-02-12 2014-12-11 S Sale GLAXOSMITHKLINE PLC Large shareholder
12,500 -0.6%
21.28
US$266,035 		12,500 -0.6% 21.28 US$266,035
2015-02-12 2014-12-10 S Sale GLAXOSMITHKLINE PLC Large shareholder
10,000 -0.5%
21.18
US$211,760 		10,000 -0.5% 21.18 US$211,760
2014-04-02 2014-04-01 B Purchase GLAXOSMITHKLINE PLC Large shareholder
103,762 +5.5%
12.00
US$1,245,144 		103,762 +5.5% 12.00 US$1,245,144
2014-04-01 2014-04-01 B Purchase Rosen James Non-Executive Director Large shareholder
62,871 +5.5%
12.00
US$754,452 		62,871 +5.5% 12.00 US$754,452
2014-04-01 2014-04-01 B Purchase MedImmune Ventures, Inc. Large shareholder
75,735 +5.5%
12.00
US$908,820 		75,735 +5.5% 12.00 US$908,820
2014-04-01 2014-04-01 B Purchase INTERWEST PARTNERS VIII LP Large shareholder
75,376 +5.5%
12.00
US$904,512 		75,376 +5.5% 12.00 US$904,512
2014-04-01 2014-04-01 B Purchase Alta Partners VIII, L.P. Large shareholder
155,645 +5.5%
12.00
US$1,867,740 		155,645 +5.5% 12.00 US$1,867,740
2014-04-01 2014-04-01 B Purchase Wu Samuel Non-Executive Director Large shareholder
75,735 +5.5%
12.00
US$908,820 		75,735 +5.5% 12.00 US$908,820
2014-04-01 2014-04-01 B Purchase Carroll Jill Non-Executive Director Large shareholder
103,762 +5.5%
12.00
US$1,245,144 		103,762 +5.5% 12.00 US$1,245,144
2014-04-01 2014-04-01 B Purchase ORONSKY ARNOLD L Non-Executive Director Large shareholder
75,736 +5.5%
12.00
US$908,832 		75,736 +5.5% 12.00 US$908,832
Explore more

More insider trading research around Applied Genetic Technologies Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America